Allegis Investment Advisors LLC purchased a new position in Steris Plc (NYSE:STE) during the second quarter, Holdings Channel reports. The institutional investor purchased 3,076 shares of the medical equipment provider’s stock, valued at approximately $251,000.
A number of other institutional investors also recently added to or reduced their stakes in the company. Investment Counselors of Maryland LLC increased its position in Steris Plc by 28.7% in the first quarter. Investment Counselors of Maryland LLC now owns 2,640 shares of the medical equipment provider’s stock worth $183,000 after buying an additional 588 shares during the last quarter. Cigna Investments Inc. New bought a new position in Steris Plc during the second quarter worth about $209,000. Aureus Asset Management LLC bought a new position in Steris Plc during the first quarter worth about $245,000. Bbva Compass Bancshares Inc. increased its position in Steris Plc by 9.2% in the first quarter. Bbva Compass Bancshares Inc. now owns 3,664 shares of the medical equipment provider’s stock worth $255,000 after buying an additional 308 shares during the last quarter. Finally, Diversified Trust Co increased its position in Steris Plc by 7.8% in the first quarter. Diversified Trust Co now owns 3,816 shares of the medical equipment provider’s stock worth $265,000 after buying an additional 275 shares during the last quarter. 92.40% of the stock is owned by institutional investors.
Steris Plc (NYSE STE) opened at 86.23 on Friday. The firm’s 50 day moving average is $83.01 and its 200-day moving average is $75.53. Steris Plc has a 52 week low of $63.80 and a 52 week high of $87.49. The company has a market cap of $7.35 billion, a P/E ratio of 61.68 and a beta of 1.33.
Steris Plc (NYSE:STE) last posted its quarterly earnings data on Tuesday, August 8th. The medical equipment provider reported $0.85 EPS for the quarter, topping the consensus estimate of $0.80 by $0.05. The firm had revenue of $608 million during the quarter, compared to analyst estimates of $597.66 million. Steris Plc had a net margin of 4.63% and a return on equity of 11.39%. Steris Plc’s revenue was down 4.8% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.79 EPS. On average, analysts predict that Steris Plc will post $4.06 earnings per share for the current fiscal year.
The company also recently disclosed a quarterly dividend, which will be paid on Thursday, September 28th. Investors of record on Tuesday, August 29th will be paid a dividend of $0.31 per share. This represents a $1.24 annualized dividend and a dividend yield of 1.44%. The ex-dividend date is Friday, August 25th. This is a positive change from Steris Plc’s previous quarterly dividend of $0.28. Steris Plc’s payout ratio is 80.00%.
TRADEMARK VIOLATION WARNING: “Allegis Investment Advisors LLC Purchases New Stake in Steris Plc (STE)” was first posted by Community Financial News and is the property of of Community Financial News. If you are reading this article on another website, it was stolen and reposted in violation of U.S. and international copyright & trademark legislation. The legal version of this article can be accessed at https://www.com-unik.info/2017/08/18/allegis-investment-advisors-llc-purchases-new-stake-in-steris-plc-ste.html.
A number of equities analysts recently issued reports on the stock. Wellington Shields downgraded shares of Steris Plc from a “gradually accumulate” rating to a “hold” rating in a research note on Monday, June 5th. BidaskClub downgraded shares of Steris Plc from a “strong-buy” rating to a “buy” rating in a research note on Monday, July 31st. Raymond James Financial, Inc. increased their price target on shares of Steris Plc from $90.00 to $95.00 and gave the stock an “outperform” rating in a research note on Wednesday, August 9th. Zacks Investment Research raised shares of Steris Plc from a “hold” rating to a “buy” rating and set a $92.00 price target for the company in a research note on Tuesday, July 11th. Finally, KeyCorp raised shares of Steris Plc from a “sector weight” rating to an “overweight” rating and set a $89.00 price target for the company in a research note on Wednesday, May 3rd. Two equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and an average target price of $86.75.
In related news, VP Sudhir K. Pahwa sold 800 shares of the business’s stock in a transaction that occurred on Thursday, May 25th. The shares were sold at an average price of $77.28, for a total transaction of $61,824.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Kathleen Bardwell sold 4,000 shares of the business’s stock in a transaction that occurred on Thursday, June 1st. The stock was sold at an average price of $79.00, for a total transaction of $316,000.00. Following the transaction, the insider now owns 20,975 shares of the company’s stock, valued at approximately $1,657,025. The disclosure for this sale can be found here. In the last quarter, insiders have sold 46,354 shares of company stock valued at $3,805,772. 2.55% of the stock is currently owned by company insiders.
About Steris Plc
STERIS plc provides infection prevention and other procedural products and services. The Company operates through four segments: Healthcare Products, which offers infection prevention and procedural solutions for healthcare providers, including capital equipment and related maintenance, and installation services, as well as consumables; Healthcare Specialty Services, which provides a range of specialty services for healthcare providers, including hospital sterilization services, instrument and scope repairs, and linen management; Life Sciences, which offers capital equipment and consumable products, and equipment maintenance and specialty services for pharmaceutical manufacturers and research facilities, and Applied Sterilization Technologies, which offers contract sterilization and laboratory services for medical device and pharmaceutical customers and others.
Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Steris Plc (NYSE:STE).
What are top analysts saying about Steris Plc? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Steris Plc and related companies.